ExploreWatchlistsPricing
  1. JP-listed companies
  2. KAKEN PHARMACEUTIAL CO., LTD.
  3. Financials
  4. Marketable securities, non-current

KAKEN PHARMACEUTIAL CO., LTD. (4521)

Market cap
¥191.8B
P/E ratio
68.7x
A Japanese pharmaceutical company that manufactures and sells medicines, medical devices, and agricultural chemicals while also operating real estate leasing.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndMarketable securities, non-current (Million JPY)YoY (%)
Mar 31, 202518,875-8.07%
Mar 31, 202420,532+17.25%
Mar 31, 202317,511+2.45%
Mar 31, 202217,093-1.58%
Mar 31, 202117,368+15.51%
Mar 31, 202015,036-11.91%
Mar 31, 201917,068-7.68%
Mar 31, 201818,488+15.96%
Mar 31, 201715,943+10.72%
Mar 31, 201614,400-6.23%
Mar 31, 201515,357

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat